Related Experiment Video
Updated: Oct 16, 2026
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
[Anti-osteolytic therapy preserves trabecular structure and mechanical properties of bone in tumor osteolysis]
1Orthopädische Universitätsklinik Stiftung Friedrichsheim, Frankfurt/Main. A.Kurth@em.uni-frankfurt.de
Purpose Of The Study:
Little is known about the effect of a tumor on the trabecular architecture, therefore we employed an animal model for the assessment of bone quality in tumor osteolysis to determine the alterations of the trabecular architecture in tumor osteolysis and after an interventional treatment with a bisphosphonate.
Methods:
To assess the bone mass and the micro-architecture of the trabecular bone in tumor osteolysis we employed a micro-computed tomography system. For the assessment of the mechanical properties of the treated and non-treated tumor-bearing bones we used a torsion test.
Results:
The presence of a tumor in bone resulted in a reduction of bone mass, stability and architectural parameters. An interventional treatment of the animals with a bisphosphonate increased the bone mineral content, mechanical and architectural parameters compared to the non-treated, tumor-bearing animals.
Conclusions:
These results clearly show a beneficial effect of an anti-osteolytic treatment with a bisphosphonate in regard of bone quality in tumor-induced osteolysis.
Insights
Tumor-induced osteolysis significantly degrades bone quality. Bisphosphonate treatment effectively improves bone mass, stability, and architecture in tumor-bearing animals, highlighting its anti-osteolytic benefits.
Area of Science:
- Orthopedics
- Oncology
- Biomaterials Science
Background:
- Tumor-induced osteolysis significantly impacts bone quality, but its effects on trabecular architecture are not well understood.
- Understanding these changes is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the alterations in trabecular architecture caused by tumor osteolysis.
- To evaluate the efficacy of bisphosphonate treatment in improving bone quality during tumor osteolysis.
Main Methods:
- Utilized a micro-computed tomography system to assess bone mass and micro-architecture.
- Employed torsion tests to evaluate the mechanical properties of tumor-bearing bones.
Main Results:
- Tumor presence led to reduced bone mass, stability, and architectural parameters.
- Bisphosphonate treatment significantly increased bone mineral content, mechanical strength, and architectural integrity compared to untreated controls.
Conclusions:
- Bisphosphonate treatment demonstrates a beneficial effect on bone quality in the context of tumor-induced osteolysis.
- This suggests bisphosphonates are a viable therapeutic strategy for managing bone loss associated with tumors.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
01:40Bone Remodeling